J&J Balks At Ark.'s $181M Risperdal Legal Fee Request
Johnson & Johnson challenged Arkansas' request for $181 million in legal fees for attorneys who secured a $1.2 billion judgment in a Medicaid fraud case over marketing of the antipsychotic drug...To view the full article, register now.
Already a subscriber? Click here to view full article